COMPOSITIONS OF EFAVIRENZ

COMPOSITIONS OF EFAVIRENZ

The present inventions relates to a solid composition and an aqueous dispersion comprising nanoparticles of the anti-retroviral drug efavirenz. The solid composition and aqueous dispersion additionally comprise a mixture of a hydrophilic polymer and a surfactant. The surfactant is selected from vita...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RANNARD, STEVEN PAUL, MARTIN, PHILIP JOHN, SMITH, DARREN LEE, OWEN, ANDREW, GIARDIELLO, MARCO NORMAN, McDONALD, THOMAS OLIVER
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RANNARD, STEVEN PAUL
MARTIN, PHILIP JOHN
SMITH, DARREN LEE
OWEN, ANDREW
GIARDIELLO, MARCO NORMAN
McDONALD, THOMAS OLIVER
description The present inventions relates to a solid composition and an aqueous dispersion comprising nanoparticles of the anti-retroviral drug efavirenz. The solid composition and aqueous dispersion additionally comprise a mixture of a hydrophilic polymer and a surfactant. The surfactant is selected from vitamin-E-polyethylene glycol-succinate (Vit-E-PEG-succinate), a polyoxyethylene sorbitan fatty acid ester, N-alkyldimethylbenzylammonium chloride, sodium deoxycholate, dioctyl sodium sulfosuccinate, polyethyleneglycol-12-hydroxystearate, polyvinyl alcohol (PVA), and a block copolymer of polyoxyethylene and polyoxypropylene, or a combination thereof. The hydrophilic polymer is suitably selected from polyvinyl alcohol (PVA), a polyvinyl alcohol-polyethylene glycol graft copolymer, a block copolymer of polyoxyethylene and polyoxypropylene, polyethylene glycol, hydroxypropyl methyl cellulose (HPMC), and polyvinylpyrrolidone, or a combination thereof. The present invention also relates to processes for preparing both the solid composition and the aqueous dispersion, as well as to their use in therapy for the treatment and/or prevention of retroviral infections such as human immunodeficiency virus (HIV).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA201402166B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA201402166B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA201402166B3</originalsourceid><addsrcrecordid>eNrjZJB09vcN8A_2DPH09wtW8HdTcHVzDPMMcvWL4mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8VGORgaGJgZGhmZmTsbEqAEAJfggKA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS OF EFAVIRENZ</title><source>esp@cenet</source><creator>RANNARD, STEVEN PAUL ; MARTIN, PHILIP JOHN ; SMITH, DARREN LEE ; OWEN, ANDREW ; GIARDIELLO, MARCO NORMAN ; McDONALD, THOMAS OLIVER</creator><creatorcontrib>RANNARD, STEVEN PAUL ; MARTIN, PHILIP JOHN ; SMITH, DARREN LEE ; OWEN, ANDREW ; GIARDIELLO, MARCO NORMAN ; McDONALD, THOMAS OLIVER</creatorcontrib><description>The present inventions relates to a solid composition and an aqueous dispersion comprising nanoparticles of the anti-retroviral drug efavirenz. The solid composition and aqueous dispersion additionally comprise a mixture of a hydrophilic polymer and a surfactant. The surfactant is selected from vitamin-E-polyethylene glycol-succinate (Vit-E-PEG-succinate), a polyoxyethylene sorbitan fatty acid ester, N-alkyldimethylbenzylammonium chloride, sodium deoxycholate, dioctyl sodium sulfosuccinate, polyethyleneglycol-12-hydroxystearate, polyvinyl alcohol (PVA), and a block copolymer of polyoxyethylene and polyoxypropylene, or a combination thereof. The hydrophilic polymer is suitably selected from polyvinyl alcohol (PVA), a polyvinyl alcohol-polyethylene glycol graft copolymer, a block copolymer of polyoxyethylene and polyoxypropylene, polyethylene glycol, hydroxypropyl methyl cellulose (HPMC), and polyvinylpyrrolidone, or a combination thereof. The present invention also relates to processes for preparing both the solid composition and the aqueous dispersion, as well as to their use in therapy for the treatment and/or prevention of retroviral infections such as human immunodeficiency virus (HIV).</description><language>eng</language><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20151223&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201402166B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20151223&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201402166B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RANNARD, STEVEN PAUL</creatorcontrib><creatorcontrib>MARTIN, PHILIP JOHN</creatorcontrib><creatorcontrib>SMITH, DARREN LEE</creatorcontrib><creatorcontrib>OWEN, ANDREW</creatorcontrib><creatorcontrib>GIARDIELLO, MARCO NORMAN</creatorcontrib><creatorcontrib>McDONALD, THOMAS OLIVER</creatorcontrib><title>COMPOSITIONS OF EFAVIRENZ</title><description>The present inventions relates to a solid composition and an aqueous dispersion comprising nanoparticles of the anti-retroviral drug efavirenz. The solid composition and aqueous dispersion additionally comprise a mixture of a hydrophilic polymer and a surfactant. The surfactant is selected from vitamin-E-polyethylene glycol-succinate (Vit-E-PEG-succinate), a polyoxyethylene sorbitan fatty acid ester, N-alkyldimethylbenzylammonium chloride, sodium deoxycholate, dioctyl sodium sulfosuccinate, polyethyleneglycol-12-hydroxystearate, polyvinyl alcohol (PVA), and a block copolymer of polyoxyethylene and polyoxypropylene, or a combination thereof. The hydrophilic polymer is suitably selected from polyvinyl alcohol (PVA), a polyvinyl alcohol-polyethylene glycol graft copolymer, a block copolymer of polyoxyethylene and polyoxypropylene, polyethylene glycol, hydroxypropyl methyl cellulose (HPMC), and polyvinylpyrrolidone, or a combination thereof. The present invention also relates to processes for preparing both the solid composition and the aqueous dispersion, as well as to their use in therapy for the treatment and/or prevention of retroviral infections such as human immunodeficiency virus (HIV).</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB09vcN8A_2DPH09wtW8HdTcHVzDPMMcvWL4mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8VGORgaGJgZGhmZmTsbEqAEAJfggKA</recordid><startdate>20151223</startdate><enddate>20151223</enddate><creator>RANNARD, STEVEN PAUL</creator><creator>MARTIN, PHILIP JOHN</creator><creator>SMITH, DARREN LEE</creator><creator>OWEN, ANDREW</creator><creator>GIARDIELLO, MARCO NORMAN</creator><creator>McDONALD, THOMAS OLIVER</creator><scope>EVB</scope></search><sort><creationdate>20151223</creationdate><title>COMPOSITIONS OF EFAVIRENZ</title><author>RANNARD, STEVEN PAUL ; MARTIN, PHILIP JOHN ; SMITH, DARREN LEE ; OWEN, ANDREW ; GIARDIELLO, MARCO NORMAN ; McDONALD, THOMAS OLIVER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA201402166B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>online_resources</toplevel><creatorcontrib>RANNARD, STEVEN PAUL</creatorcontrib><creatorcontrib>MARTIN, PHILIP JOHN</creatorcontrib><creatorcontrib>SMITH, DARREN LEE</creatorcontrib><creatorcontrib>OWEN, ANDREW</creatorcontrib><creatorcontrib>GIARDIELLO, MARCO NORMAN</creatorcontrib><creatorcontrib>McDONALD, THOMAS OLIVER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RANNARD, STEVEN PAUL</au><au>MARTIN, PHILIP JOHN</au><au>SMITH, DARREN LEE</au><au>OWEN, ANDREW</au><au>GIARDIELLO, MARCO NORMAN</au><au>McDONALD, THOMAS OLIVER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS OF EFAVIRENZ</title><date>2015-12-23</date><risdate>2015</risdate><abstract>The present inventions relates to a solid composition and an aqueous dispersion comprising nanoparticles of the anti-retroviral drug efavirenz. The solid composition and aqueous dispersion additionally comprise a mixture of a hydrophilic polymer and a surfactant. The surfactant is selected from vitamin-E-polyethylene glycol-succinate (Vit-E-PEG-succinate), a polyoxyethylene sorbitan fatty acid ester, N-alkyldimethylbenzylammonium chloride, sodium deoxycholate, dioctyl sodium sulfosuccinate, polyethyleneglycol-12-hydroxystearate, polyvinyl alcohol (PVA), and a block copolymer of polyoxyethylene and polyoxypropylene, or a combination thereof. The hydrophilic polymer is suitably selected from polyvinyl alcohol (PVA), a polyvinyl alcohol-polyethylene glycol graft copolymer, a block copolymer of polyoxyethylene and polyoxypropylene, polyethylene glycol, hydroxypropyl methyl cellulose (HPMC), and polyvinylpyrrolidone, or a combination thereof. The present invention also relates to processes for preparing both the solid composition and the aqueous dispersion, as well as to their use in therapy for the treatment and/or prevention of retroviral infections such as human immunodeficiency virus (HIV).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_ZA201402166B
source esp@cenet
title COMPOSITIONS OF EFAVIRENZ
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T10%3A38%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RANNARD,%20STEVEN%20PAUL&rft.date=2015-12-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA201402166B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true